Author
K. H. Kaestner
Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.
Biology Disciplines
Click to filter author papersSignature Assays, Organisms & Methods
Click to filter · or open tagActivity by Year
2019-2021 · peak 2/yrCo-Author Collaboration Network
10 top collaborators · 16 mutual co-author links4 papers
Recent·Most cited
- Cancer BiologybioRxivPreprint
FoxA1 and FoxA2 regulate growth and cellular identity in NKX2-1-positive lung adenocarcinoma
G. Orstad, G. Fort, T. J. Parnell…·E. L. Snyder
This study shows that FoxA1/2 are critical for tumorigenesis and cellular identity in NKX2-1-positive lung adenocarcinoma, with their loss impairing tumor growth and altering transcriptional programs.
- Cell BiologybioRxivPreprint
SARS-CoV-2 Cell Entry Factors ACE2 and TMPRSS2 are Expressed in the Pancreas but are Not Enriched in Islet Endocrine Cells
K. C. Coate, J. Cha, S. Shrestha…·A. C. Powers
The paper examines ACE2 and TMPRSS2 expression in the human pancreas and finds they are not enriched in islet endocrine cells, suggesting SARS-CoV-2 may not directly infect beta cells through these proteins.
DOI 10.1101/2020.08.31.275719 - Cancer BiologybioRxivPreprint
In vivo screen identifies LXR agonism potentiates sorafenib killing of hepatocellular carcinoma
M. E. Preziosi, A. M. Zahm, A. Vasquez-Salgado…·K. J. Wangensteen
The paper identifies LXR agonism as a potential enhancer of sorafenib's efficacy in treating hepatocellular carcinoma through an in vivo genetic screen and mechanistic studies.
DOI 10.1101/668350